We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
In this study, 6 popular biofortified cultivars were field-evaluated for their response to plant parasitic nematodes in Nigeria
MV Chinfield antifatigue bronchospasmolytic for thoroughbreds seized at a Belfast courier company.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Employment Appeal Tribunal Judgment of Mr Justice Bourne on 24 April 2024.
Information to support your recovery after COVID-19.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Oct - 31 Dec 2023.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Form L7 for the isolation, identification and toxin detection of clostridium botulinum and Staphylococcus aureus.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Advice and guidance on the health needs of migrant patients from El Salvador for healthcare practitioners.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Laboratories can use these templates to notify relevant clinicians of a presumed positive blood spot screening result for cystic fibrosis (CF).
Volume 43 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.